motilin-(1-19) (human) [5296]



motilin-(1-19) (human)


SMILES CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O
InChIKey MGEPJYBDTTYXQQ-AKGJPERPSA-N
Sequence FVPIFTYGELQRMQEKERN
HELM PEPTIDE1{F.V.P.I.F.T.Y.G.E.L.Q.R.M.Q.E.K.E.R.N}$$$$

Chemical Properties

Hydrogen bond acceptors 32
Hydrogen bond donors 32
Rotatable bonds 80
Log P -8.185
Molecular weight (Da) 2384.2
Stereochemistry info partial

Database connections

Model (AF2) motilin


No bioactivity data available.

motilin-(1-19) (human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) motilin


Compound is not listed as a drug.